Compare Gemini Space Station Inc (GEMI) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Gemini Space Station Inc trades at $4.4 (market cap $579.55M), while Iovance Biotherapeutics Inc. Common Stock trades at $13.45 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 10.4× Gemini Space Station Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GEMI | IOVA | |
|---|---|---|
Market Cap | $579.55M | $6.04B |
Volume | 1,882,406 | 14,805,993 |
Sector | Financials | Health |
52-Week High | $25.41 | $14.82 |
52-Week Low | $3.54 | $1.81 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | $558.57M | $5.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.49, down 3.85% amid bearish technical signals despite recent 31% surge. The company shows concerning fundamentals with negative gross profit margin of -70.25% and net income margin of -250.13% for 2025. Revenue grew 37% YoY in Q2 2026 to $207M, but losses persist with $517M net loss. Analyst consensus is mixed with 33% buy ratings and $5.33 price target, while technical indicators show oversold conditions with RSI at 16.87.
GEMI presents high-risk speculation with significant operational challenges despite revenue growth. The stock's viability depends on reversing deep losses and achieving profitability. Near-term catalysts include SEC's tokenized stock trading pathway, but class action lawsuits and persistent cash burn pose substantial downside risk. Current valuation at 2.75 P/S appears stretched given negative margins.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
